Cargando…
Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance
PURPOSE: Cardiac comorbidity is one of the leading causes of death among acromegaly patients. We aimed to investigate the reversibility of acromegalic cardiac involvement after surgical treatment using the gold standard method, cardiovascular magnetic resonance, and to explore the effects of endocri...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609918/ https://www.ncbi.nlm.nih.gov/pubmed/33193111 http://dx.doi.org/10.3389/fendo.2020.598948 |
_version_ | 1783605096141029376 |
---|---|
author | Guo, Xiaopeng Cao, Yihan Cao, Jian Li, Xiao Liu, Peijun Wang, Zihao Gao, Lu Bao, Xinjie Xing, Bing Wang, Yining |
author_facet | Guo, Xiaopeng Cao, Yihan Cao, Jian Li, Xiao Liu, Peijun Wang, Zihao Gao, Lu Bao, Xinjie Xing, Bing Wang, Yining |
author_sort | Guo, Xiaopeng |
collection | PubMed |
description | PURPOSE: Cardiac comorbidity is one of the leading causes of death among acromegaly patients. We aimed to investigate the reversibility of acromegalic cardiac involvement after surgical treatment using the gold standard method, cardiovascular magnetic resonance, and to explore the effects of endocrine remission and gender on reversibility. METHODS: In this single-center, prospective cohort study, fifty untreated acromegaly patients were enrolled. Comprehensive cardiac assessments were performed using a 3.0 T magnetic resonance scanner before and 3 and 12 months after transsphenoidal adenomectomy. RESULTS: Preoperatively, left ventricular (LV) enlargement (13.0%), LV systolic dysfunction (6.5%), right ventricular (RV) enlargement (4.3%), RV systolic dysfunction (2.2%) and myocardial fibrosis (12.0%) were identified. On average, the LV and RV ejection fractions of acromegaly patients were higher than the healthy reference values. Male patients had thicker LV myocardia, wider ventricular diameters and more dilated pulmonary artery roots than female patients. After surgery, LV myocardial hypertrophy was reversed, the left atrium was remodeled, and ventricular systolic dysfunction recovered to normal. Cardiac alterations were detected early in the 3(rd) postoperative month and persisted until the 12(th) month. The interventricular septum was initially thickened in the 3(rd) postoperative month and then recovered at the 12th month. Notable postoperative cardiac reversibility was observed in male patients but did not occur in all female patients. Patients achieving endocrine remission with normalized hormone levels had thinner LV myocardia than patients without normalized hormone levels. CONCLUSION: Our findings demonstrated that some of the cardiac involvement in acromegaly patients is reversible after surgical treatment which lowers hormone levels. Endocrine remission and gender significantly impacted postoperative cardiac reversibility. |
format | Online Article Text |
id | pubmed-7609918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76099182020-11-13 Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance Guo, Xiaopeng Cao, Yihan Cao, Jian Li, Xiao Liu, Peijun Wang, Zihao Gao, Lu Bao, Xinjie Xing, Bing Wang, Yining Front Endocrinol (Lausanne) Endocrinology PURPOSE: Cardiac comorbidity is one of the leading causes of death among acromegaly patients. We aimed to investigate the reversibility of acromegalic cardiac involvement after surgical treatment using the gold standard method, cardiovascular magnetic resonance, and to explore the effects of endocrine remission and gender on reversibility. METHODS: In this single-center, prospective cohort study, fifty untreated acromegaly patients were enrolled. Comprehensive cardiac assessments were performed using a 3.0 T magnetic resonance scanner before and 3 and 12 months after transsphenoidal adenomectomy. RESULTS: Preoperatively, left ventricular (LV) enlargement (13.0%), LV systolic dysfunction (6.5%), right ventricular (RV) enlargement (4.3%), RV systolic dysfunction (2.2%) and myocardial fibrosis (12.0%) were identified. On average, the LV and RV ejection fractions of acromegaly patients were higher than the healthy reference values. Male patients had thicker LV myocardia, wider ventricular diameters and more dilated pulmonary artery roots than female patients. After surgery, LV myocardial hypertrophy was reversed, the left atrium was remodeled, and ventricular systolic dysfunction recovered to normal. Cardiac alterations were detected early in the 3(rd) postoperative month and persisted until the 12(th) month. The interventricular septum was initially thickened in the 3(rd) postoperative month and then recovered at the 12th month. Notable postoperative cardiac reversibility was observed in male patients but did not occur in all female patients. Patients achieving endocrine remission with normalized hormone levels had thinner LV myocardia than patients without normalized hormone levels. CONCLUSION: Our findings demonstrated that some of the cardiac involvement in acromegaly patients is reversible after surgical treatment which lowers hormone levels. Endocrine remission and gender significantly impacted postoperative cardiac reversibility. Frontiers Media S.A. 2020-10-21 /pmc/articles/PMC7609918/ /pubmed/33193111 http://dx.doi.org/10.3389/fendo.2020.598948 Text en Copyright © 2020 Guo, Cao, Cao, Li, Liu, Wang, Gao, Bao, Xing and Wang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Guo, Xiaopeng Cao, Yihan Cao, Jian Li, Xiao Liu, Peijun Wang, Zihao Gao, Lu Bao, Xinjie Xing, Bing Wang, Yining Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance |
title | Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance |
title_full | Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance |
title_fullStr | Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance |
title_full_unstemmed | Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance |
title_short | Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance |
title_sort | reversibility of cardiac involvement in acromegaly patients after surgery: 12-month follow-up using cardiovascular magnetic resonance |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609918/ https://www.ncbi.nlm.nih.gov/pubmed/33193111 http://dx.doi.org/10.3389/fendo.2020.598948 |
work_keys_str_mv | AT guoxiaopeng reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance AT caoyihan reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance AT caojian reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance AT lixiao reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance AT liupeijun reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance AT wangzihao reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance AT gaolu reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance AT baoxinjie reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance AT xingbing reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance AT wangyining reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance |